1. Healthcare

haematologica
Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
Table of Contents
Volume 100, Issue 2: February 2015
Cover Figure
Artistic view on the structure of Factor VIII.
(image created by www.somersault1824.com)
Editorials
143
Tumor-associated macrophages in diffuse large B-cell lymphoma
Robert Kridel, et al.
145
Inherited thrombocytopenias in the era of personalized medicine
Patrizia Noris, et al.
Review Article
149
Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity
Johannes Oldenburg, et al.
Articles
Hematopoiesis
157
In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis
Stijn Vanhee, et al.
Iron Metabolism & its Disorders
167
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression
in established and novel models of dysregulated iron homeostasis
Patrick Gutschow, et al.
Red Cell Biology & its Disorders
178
Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion
Mario Falchi, et al.
Coagulation & its Disorders
188
Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism
Tom van der Hulle, et al.
Myelodysplastic Syndromes
194
Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities
of mesenchymal stromal cells in patients with myelodysplastic syndrome
Youshan Zhao, et al.
205
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH:
results from a German diagnostic study in comparison with an international control group
Friederike Braulke, et al.
Haematologica 2015; vol. 100 no. 2 - February 2015
http://www.haematologica.org/
haematologica
Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
Acute Myeloid Leukemia
214
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
Niccolò Bolli, et al.
223
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre, et al.
231
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia
Jeffrey E. Lancet, et al.
Non-Hodgkin Lymphoma
238
Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
Sari Riihijärvi, et al.
246
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection
Luca Arcaini, et al.
Chronic Lymphocytic Leukemia
253
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
Stefania Fiorcari, et al.
Plasma Cell Disorders
263
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody
IPH2102 and lenalidomide
Inger S. Nijhof, et al.
Stem Cell Transplantation
269
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic
stem cell transplantation: a prospective multicenter phase II trial
Didier Blaise, et al.
275
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease
Isabelle Laverdière, et al.
Complications in Hematology
284
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed
acute myeloid leukemia (SEIFEM 2010-a multicenter study)
Morena Caira, et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/100/2.toc
e42
IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors
Chiara Vitale, et al.
http://www.haematologica.org/content/100/2/e42
e46
JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
Shuichi Shirane, et al.
http://www.haematologica.org/content/100/2/e46
e49
Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts
Elizabeth A. Griffiths, et al.
http://www.haematologica.org/content/100/2/e49
Haematologica 2015; vol. 100 no. 2 - February 2015
http://www.haematologica.org/
haematologica
Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
e53
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
Bruno Paiva, et al.
http://www.haematologica.org/content/100/2/e53
e56
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma:
the Intergroupe Francophone du Myelome 2009-01 trial
Philippe Rodon, et al.
http://www.haematologica.org/content/100/2/e56
e60
A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia
Anna Kalff, et al.
http://www.haematologica.org/content/100/2/e60
e63
Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone
in relapsed and/or refractory multiple myeloma
Kevin W. Song, et al.
http://www.haematologica.org/content/100/2/e63
e68
Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia
of inflammation
Claire Mayeur, et al.
http://www.haematologica.org/content/100/2/e68
e72
Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency
Polina Stepensky, et al.
http://www.haematologica.org/content/100/2/e72
Haematologica 2015; vol. 100 no. 2 - February 2015
http://www.haematologica.org/